Table 1 Comparison of groups with non‐recurrent and recurrent lupus enteritis at initial admission.
| Non‐recurrent group (n = 7) | Recurrent group (n = 9) | p Value | |||
|---|---|---|---|---|---|
| Age (years)* | 32.1 (9.4) | 30.0 (6.3) | 0.75 | ||
| Sex | |||||
| Male | 1 | 1 | 0.70 | ||
| Female | 6 | 8 | 0.70 | ||
| White cell count (×109)/l* | 8.6 (4.7) | 5.4 (0.9) | 0.12 | ||
| Haemoglobin (g/l)* | 10.9 (2.6) | 12.1 (1.4) | 0.05 | ||
| Platelets (×109)/l* | 259.0 (88.7) | 257.6 (103.3) | 0.71 | ||
| ESR (mm/1/h)* | 52.1 (18.1) | 41.3 (19.2) | 0.34 | ||
| CRP (mg/l)* | 4.2 (4.2) | 1.6 (3.1) | 0.15 | ||
| C3 (mg/l)* | 56.2 (13.2) | 48.0 (9.0) | 0.24 | ||
| C4 (mg/l)* | 13.4 (5.1) | 13.0 (6.5) | 0.23 | ||
| Anti‐dsDNA (IU/ml)* | 69.8 (65.2) | 128.7 (156.2) | 0.87 | ||
| SLEDAI score* | 7.6 (6.0) | 7.9 (4.7) | 0.75 | ||
| PD cumulative dose (g)* | 14.7 (6.0) | 7.6 (2.4) | 0.02 | ||
| Duration of PD treatment (month)* | 50.0 (32.8) | 16.9 (7.4) | 0.04 | ||
| Thickness of bowel wall† (mm)* | 6.1 (2.6) | 9.0 (3.7) | 0.08 | ||
C, complement; CRP, C‐reactive protein; ESR, erythrocyte sedimentation rate; PD, prednisolone; SLEDAI, systemic lupus erythematosus disease activity index.
*Values are given as mean (SD).
†Measured at the most thickened site in the affected bowel on abdominal computed tomography scan.